Submit a notification by the deadline to keep active substances in the GB Review Programme The deadlines for resubmitting pending active substance applications to HSE have now passed. Several active substance/product type combinations that were being evaluated as part of the EU Review Programme have not been resubmitted to Great Britain (GB). HSE has published open invitations to provide an opportunity for a person, company or task force/consortium to notify an intention to take over the role of participant in the GB Review Programme for these active substance/product type combinations. Find out which active substance/product type combinations have open invitations. IMPORTANT: The open invitation list contains active substance/product type combinations that have not yet been supported in GB – product manufacturers are advised to check the list to find out if the active substances used in their products are affected and to raise this with their active substance suppliers. Anyone wishing to support one of the active substance/product type combinations on the list in GB will need to submit a notification to HSE by 12 November 2022. If a notification to take over the role of participant is not received, these active substance/product type combinations will be subject to a GB non-approval decision. Biocidal products containing active substances with GB non-approval decisions for the relevant product types will have to be removed from the GB market. HSE will provide separate updates on these where relevant. If you are aware of any disproportionate negative effects that are likely to arise from the non-approval of any of the active substance/product type combinations listed above, please contact us. Make sure you are receiving important information about your product authorisations and approvals If you hold product authorisations and approvals in Great Britain under the GB BPR or the Control of Pesticides Regulations (COPR), you should make sure HSE has the right contact details for you. If the details we hold are out of date, you may not receive important information about your product authorisation or approval. Update your details. | 
No comments:
Post a Comment